November 30, 2022

Conagen develops high-purity non-GMO sulforaphane by bioconversion

Commercial production is underway for 2023. Bedford, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Expanding on its portfolio of innovative nutritional products through biotechnology, Conagen, announced the development of its 99% high-purity sulforaphane. Made by a proprietary bioconversion technology, the company plans to begin the commercialization path in 2023. Conagen’s

>

Azerion sets out its future strategic priorities

Amsterdam, 30 November 2022 – Today, Azerion has set out its strategic priorities in the journey to become the go-to-partner for advertisers for an easy-to-use, competitively priced and brand-safe digital environment. The Strategy Deep Dive presentation is available on www.azerion.com/investors. Umut Akpinar, co-CEO of Azerion, comments: “I am excited to share

>